Preclinical Research

Medicilon is a Preclinical Research Outsourcing (CRO) company. With more than 20 years of experience on preclinical research services, we are dedicated to provide our clients with customized preclinical services program in drug metabolism, pharmacokinetics, efficacy studies, and toxicology. We provide our clients a high-quality data and rapid turnaround time to support their drug development, preclinical studies and clinical research and to help them to select the most valuable drug candidates for clinical development.

Medicilon's preclinical research services consist of three major parts: pharmacokinetics, disease models and drug safety evaluation. Our preclinical research services cover design, in vivo studies, sample analysis, data analysis, IACUC review, and the preparation of regulatory application materials.

Preclinical Research Services

Quick start experiments and our flexible experimental design help you to speed up your decisions and lower your research cost.
Medicilon's Preclinical Research Division services include toxicology, pharmacology and efficacy studies, absorption, distribution, metabolism, and excretion (ADME), drug metabolism and pharmacokinetics (DMPK), as well as bioanalytical solutions for small molecules, biologics, and natural products.
Drug Metabolism and PharmacokineticsPharmacology Services (Animal Models)Preclinical Drug Safety Evaluation GLP & NON-GLPBioanalysis

Complete Preclinical Research Laboratories

Medicilon's labs are certified by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) and comply with the GLP standards of the US FDA and NMPA agencies. Our preclinical safety experiments also comply with the Organization for Economic Cooperation and Development in Europe (OECD) GLP requirements.
We maintain a large in-house library of animal disease models to meet the research demands of diverse therapeutic areas. Medicilon can also assist clients in the preparation of a preclinical safety evaluation package.

Certification

Medicilon offers preclinical animal testing service for the global pharmaceutical market. Technologies provided by Medicilon such as Drugs Safety Evaluation for Non-Human Primates Services Platform and Isotope Drug Metabolism Professional Services Platform are certified by the Shanghai government. In addition, our platform is certified and identified as an important drug discovery platform by the Shanghai government.

Medicilon’s Advantages

Extensive pharmaceutical drug discovery and development expertise in small molecules (NCE), biologics, and natural products for all therapeutic modalities Full AAALAC accredited laboratories and facilities400⁺ oncology models and 230⁺ non-tumor disease models for safety and efficacy assessmentA full range of bioanalytical services and global regulatory affairs to enable successful IND submissionIT platforms such as Watson LIMS software and Provantis ensure seamless data sharing, submission (SEND format), and securityDedicated research scientists with flexible capacity provide a high quality and cost efficient service

Service Cases

Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval.webp

Medicilon Assists | China's First CD19×CD3×CD28 Trispecific Antibody Obtained FDA Implicit Approval

Learn More

Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials.webp

Medicilon Assistant| Jimincare's lgE Antibody Drug JYB1904 has been Approved for Clinical Trials

Learn More

Sinovent's New Class 1 Anti-tumor Drug XNW14010 has been Approved for Clinical Trials.webp

Sinovent's New Class 1 Anti-tumor Drug XNW14010 has been Approved for Clinical Trials

Learn More

For more service cases, please contact us:

Inquire